Nachrichten zur Johnson Service Group PLC Aktie

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

Johnson & Johnson (JNJ) closed at $263.4 in the latest trading session, marking a -1.44% move from the prior day.…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

Johnson & Johnson doesnt need GLP-1 drugs to grow, and thats good news for long-term investors.…

[Latest] Global Gauze Bandage Rolls Market Size/Share Worth USD 3.19 Billion by 2035 at a 4.97% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Gauze…

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How…

Johnson & Johnson snaps six straight sessions of gains

…

Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?

Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The…

Johnson & Johnson Aktie: Weiteres Potenzial vor den Zahlen

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Guggenheim Securities:Guggenheim-Analyst Vamil Divan habe das Kursziel für die Aktie von Johnson…

J&J CEO Now Sees Line of Sight to Double-Digit Growth for His $100 Billion Company. Heres Why Investors Should Pay Attention.

Johnson & Johnson is a healthcare giant, but an opportunity to invest in the United States and a plethora of…

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

Johnson & Johnson (JNJ) concluded the recent trading session at $244.88, signifying a +1.61% move from its prior days close.…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

Ausbruch dank Novo Nordisk, UnitedHealth und Johnson & Johnson?

Der Chart sieht spannend aus. Dank der zuletzt soliden Performance von Aktien wie UnitedHealth, Novo Nordisk oder Johnson & Johnson…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Top Research Reports for Alphabet, Broadcom & Johnson & Johnson

Todays Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Broadcom Inc. (AVGO) and Johnson…

Johnson & Johnson to invest $1 billion in vision operations in Jacksonville

With $12 million in city incentives in hand, the company is building a distribution center in Northwest Jacksonville and upgrading…

Johnson & Johnson (JNJ) Rises Higher Than Market: Key Facts

Johnson & Johnson (JNJ) closed at $240.87 in the latest trading session, marking a +1.07% move from the prior day.…

Johnson & Johnson bets $1 billion on hard-to-treat cancer

Johnson & Johnson (JNJ) is one of the biggest names in health care, and lately, its stock has been living…

Johnson & Johnson to buy Firefly Bio for $1 billion

Johnson & Johnson said ?on Monday it will acquire ?biotech Firefly Bio for $1 billion in cash, as it ?looks…

Why Johnson & Johnson May Be the Closest Thing Investors Can Find to a Bulletproof Dividend Stock

Johnson & Johnson takes a licking, and the dividend keeps on ticking higher.…

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

In the latest trading session, Johnson & Johnson (JNJ) closed at $228.17, marking a +2.21% move from the previous day.…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

BEERSE, BELGIUM , June 03, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced nipocalimab met the…

Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade

Johnson & Johnson (JNJ) reached $225.33 at the closing of the latest trading day, reflecting a -2.37% change compared to…

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer

Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer are benefiting from innovation, pipeline growth and strong demand in key…

HURA: Refining TBS-2025 Development Plan

By John Vandermosten, CFANASDAQ: HURAREAD THE FULL HURA RESEARCH REPORTOperational and Financial ResultsOn May 15th, 2026, TuHURA Biosciences, Inc. (NASDAQ:…

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Todays Market

Johnson & Johnson sells products that are necessities, not just nice-to-haves.…

Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know

In the latest trading session, Johnson & Johnson (JNJ) closed at $231.73, marking a +1.05% move from the previous day.…

Top Stock Reports for Johnson & Johnson, Oracle & Netflix

Johnson & Johnson, Oracle and Netflix lead Zacks top stock reports as analysts spotlight growth drivers, cloud gains and new…

These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets

ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.…

These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets

ExxonMobil, Johnson & Johnson, and Coca-Cola are safe stocks to buy and forget.…

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Data presented by Johnson & Johnson at the 2026 European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting Data presented…

Why Is Johnson & Johnson (JNJ) Down 3.5% Since Last Earnings Report?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy?

Its hard to argue against its reliability.…

Johnson & Johnson reaches a milestone for one of its most exciting pipeline products

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

How Ketamine Spawned a $1.7 Billion J&J Blockbuster Drug

Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to…

J&J sees AI halving the time to generate drug development leads

Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for…

Johnson & Johnson to launch on TrumpRx with four of its prescription drugs, CBS News reports

Johnson & Johnson will start marketing four of its ?medications on the Trump administrations TrumpRx website on Friday, CBS News…

Jim Cramer Called Johnson & Johnson “The Best Drug Stock, or at Least the Second-Best”

Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s stock calls on Mad Money recently. Cramer highlighted buying the stock for…

Guggenheim raises Johnson & Johnson stock price target on Icotyde

Guggenheim raises Johnson & Johnson stock price target on Icotyde…

Is Johnson & Johnson a Buy After Its Q1 2026 Earnings Report?

Solid results werent impressive enough to move the stock price higher.…

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims

US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims…

Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson: Ausblick leicht angehoben

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI):Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript

…

Johnson & Johnson’s Spravato sales growth signals upside for psychedelics peers like AtaiBeckley

Johnson & Johnson (NYSE:JNJ)’s Spravato is reinforcing investor interest in the broader psychedelics sector as it reported another quarter of…

J&Js first-quarter profit beats estimates even as Stelara sales disappoint

Johnson & Johnson reported first-quarter earnings that beat Wall Street expectations on Tuesday and raised its full-year forecast, as strong…

Johnson & Johnson beats quarterly revenue estimates, maintains full-year outlook

Johnson & Johnson (NYSE:JNJ) reported first-quarter results on Tuesday that beat Wall Street expectations for revenue, driven by solid growth…